These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11698152)

  • 1. Impairment of the neuronal dopamine transporter activity in MPP(+)-treated rat was not prevented by treatments with nitric oxide synthase or poly(ADP-ribose) polymerase inhibitors.
    Barc S; Page G; Barrier L; Piriou A; Fauconneau B
    Neurosci Lett; 2001 Nov; 314(1-2):82-6. PubMed ID: 11698152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive alteration of neuronal dopamine transporter activity in a rat injured by an intranigral injection of MPP+.
    Barc S; Page G; Barrier L; Huguet F; Fauconneau B
    Brain Res; 2002 Jun; 941(1-2):72-81. PubMed ID: 12031549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-methyl-4-phenylpyridinium (MPP+) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Deltapsi(m)) in rat striatum.
    Nakai M; Mori A; Watanabe A; Mitsumoto Y
    Exp Neurol; 2003 Jan; 179(1):103-10. PubMed ID: 12504872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
    Kurosaki R; Muramatsu Y; Michimata M; Matsubara M; Kato H; Imai Y; Itoyama Y; Araki T
    Neurol Res; 2002 Oct; 24(7):655-62. PubMed ID: 12392201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat.
    Barc S; Page G; Barrier L; Garreau L; Guilloteau D; Fauconneau B; Chalon S
    J Neurochem; 2002 Feb; 80(3):365-74. PubMed ID: 11905985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.
    Callier S; Morissette M; Grandbois M; Pélaprat D; Di Paolo T
    Synapse; 2001 Aug; 41(2):131-8. PubMed ID: 11400179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study.
    Watanabe H; Muramatsu Y; Kurosaki R; Michimata M; Matsubara M; Imai Y; Araki T
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):93-104. PubMed ID: 15013024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB; Reuben M
    Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.
    Van Kampen JM; McGeer EG; Stoessl AJ
    Synapse; 2000 Sep; 37(3):171-8. PubMed ID: 10881039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Methyl-4-phenylpridinium (MPP+)-induced functional run-down of GABA(A) receptor-mediated currents in acutely dissociated dopaminergic neurons.
    Wu J; Chan P; Schroeder KM; Ellsworth K; Partridge LD
    J Neurochem; 2002 Oct; 83(1):87-99. PubMed ID: 12358732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral Administration of Tetanus Toxin Hc Fragment Prevents MPP
    Moreno-Galarza N; Mendieta L; Palafox-Sánchez V; Herrando-Grabulosa M; Gil C; Limón DI; Aguilera J
    Neurotox Res; 2018 Jul; 34(1):47-61. PubMed ID: 29460114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease.
    Watanabe Y; Himeda T; Araki T
    Med Sci Monit; 2005 Jan; 11(1):RA17-23. PubMed ID: 15614202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats.
    Pain S; Barrier L; Deguil J; Milin S; Piriou A; Fauconneau B; Page G
    Toxicology; 2008 Jan; 243(1-2):124-37. PubMed ID: 18037221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
    Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
    J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new in vitro approach for investigating the MPTP effect on DA uptake.
    Barc S; Page G; Fauconneau B; Barrier L; Huguet F
    Neurochem Int; 2001 Mar; 38(3):243-8. PubMed ID: 11099783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.
    Przedborski S; Jackson-Lewis V; Yokoyama R; Shibata T; Dawson VL; Dawson TM
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4565-71. PubMed ID: 8643444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation.
    Fonck C; Baudry M
    Brain Res; 2001 Jun; 905(1-2):199-206. PubMed ID: 11423095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D; Samantaray S; Mohanakumar KP
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.
    Du Y; Ma Z; Lin S; Dodel RC; Gao F; Bales KR; Triarhou LC; Chernet E; Perry KW; Nelson DL; Luecke S; Phebus LA; Bymaster FP; Paul SM
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14669-74. PubMed ID: 11724929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of dopamine transporter system on 1-methyl-4-phenylpyridinium and rotenone effect in striatal synaptosomes.
    Bougria M; Vitorica J; Cano J; Machado A
    Eur J Pharmacol; 1995 Nov; 291(3):407-15. PubMed ID: 8719427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.